Back to Results
First PageMeta Content
Organic chemistry / Medicine / Ustekinumab / Psoriasis / Chemistry / Methadone


The COMET Trial: Clinical Results in Moderate to Severe RA
Add to Reading List

Document Date: 2014-06-09 11:19:23

Open Document

File Size: 187,77 KB

Share Result on Facebook

City

Dallas / Toronto / Nice / /

Company

Syntrix Biosystems / Eli Lilly / Pfizer / Anacor / Abbott / Amgen Inc. / Novartis / Sirtris / Merck / Warner Chilcott / Allergan / Stiefel / Galderma / Maruho / Schering Plough / Celgene / LEO Pharma / Wyeth / AstraZeneca / Janssen / Incyte / Novo Nordisk / Glaxo Smith Kline / Vascular Biogenics / 5Amgen Inc. / MedImmune / /

Country

France / United States / Canada / /

/

Event

FDA Phase / /

Facility

Louis University / University Medical Center / /

IndustryTerm

investigational product / /

MedicalCondition

esophageal adenocarcinoma / fatal aortic aneurysm / disease / arthralgia / nasopharyngitis / significantly improved plaque psoriasis / aortic aneurysm / acute cholecystitis / arthralgias / benign parathyroid tumor / Psoriasis / constipation / upper respiratory tract infections / upper respiratory tract infection / moderate-tosevere plaque psoriasis / /

Organization

3Baylor University Medical Center / Louis University / St. Louis / Canadian Dermatology Association / /

Person

A. Papp / /

Position

static Physician / investigator / consultant / Consultant / speaker / and investigator / consultant / speaker / /

Product

Extension / /

SocialTag